1. Recurrent
primary biliary cirrhosis (PBC) after
transplantation is controversial, but most studies support disease recurrence within the graft. 2. Granulomatous destructive
cholangitis should be present, and exclusion of acute and chronic rejection, graft-versus-host disease, biliary obstruction, viral
hepatitis, and
drug effects is mandatory before making a diagnosis of recurrent PBC. 3. Recurrent
primary sclerosing cholangitis (PSC) after
transplantation is difficult to diagnose because of the lack of a diagnostic gold standard. 4. Well-defined cholangiographic and histological criteria should be present, and exclusion of preservation injury,
blood group type incompatibility between donor and recipient, chronic rejection, hepatic
arterial occlusion, and
viral infection is mandatory before making a diagnosis of recurrent PSC. 5. Most studies support recurrent
autoimmune hepatitis (AIH) after
transplantation based on clinical, biochemical, serological, and histological criteria. Exclusion of rejection,
viral infection,
drug effects, and biliary obstruction is mandatory before making a diagnosis of recurrent AIH. 6. Intermediate-term patient and graft survival are excellent for patients with recurrent autoimmune
liver diseases within the transplanted liver, but additional studies are required to address the impact of disease recurrence on long-term patient and graft survival.